Why is $RYTM moving today? · SEC 8-K archive
T0 SEO archive for $RYTM: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).
$RYTM triggered a Stock Catalyst AI alert on 2026-11-03 00:00:00 UTC for a SEC 8-K filing (AI Score: +4.5/10). Headline: Rhythm Pharmaceuticals Reports Q3 2026: IMCIVREE Net Revenue Up 29% QoQ to $92.1M. Key points: - IMCIVREE global net product revenue reached $92.1M in Q3 2026, up 29% QoQ and 80% YoY. - Net loss per share narrowed to -$0.61 from -$0.82 in Q3 2025; total Q3 net loss was -$41.4M. - Strong U.S. launch momentum with over 700 patient start forms for hypothalamic obesity.
After the SEC 8-K for $RYTM, observed market reaction: T0 price $93.44; 4h move -9.05%. Past moves do not guarantee future results.
Stock Catalyst AI pushes real-time SEC 8-K alerts for $RYTM via Telegram and the VIP Web Terminal from €10/month.